In cultured primary BMDCs, genetic or pharmacological inhibition of the 5-lipoxygenase pathway in monocytes attenuated MMD induced by HMGB1, an endogenous damage-associated molecular patterns. This evidence concerns the gene HMGB1 and multiminicore myopathy.